ARTICLE | Company News
Pelican, Cancer Prevention & Research Institute of Texas cancer news
May 30, 2016 7:00 AM UTC
CPRIT awarded Pelican a $15.3 million New Company Product Development Award to develop agonists directed at tumor necrosis factor (TNF) receptor superfamily member 25 ( TNFRSF25; DR3; LARD; TRAMP; ...